Presentation AHA 2023 Lepodisiran: An Extended-Duration siRNA Targeting Lipoprotein(a) Presenter: Steven E. Nissen November 11, 2023 REGISTER for free or LOG IN to view this content Clinical Cardiology Prevention Clinical Pharma Lipids Presentation AHA 2023 Up Next Presentation AHA 2023 Safety and Pharmacodynamic Effects of VERVE-101 Presenter: Andrew Bellinger November 11, 2023 More slides + Presentation AHA 2023 Screening For Peripartum Cardiomyopathies Using An AI-Enhanced Digital Stethoscope: A Randomized Clinical Trial Presenter: Demilade Adedinsewo November 13, 2023 Presentation AHA 2023 Two Randomized Controlled Trials of Nudges to Encourage Referrals to Centralized Pharmacy Services for Evidence-Based Statin Initiation in High-Risk Patients: The SUPER LIPID Program Presenter: Alexander C. Fanaroff November 13, 2023 We Recommend
Presentation AHA 2023 Safety and Pharmacodynamic Effects of VERVE-101 Presenter: Andrew Bellinger November 11, 2023
Presentation AHA 2023 Screening For Peripartum Cardiomyopathies Using An AI-Enhanced Digital Stethoscope: A Randomized Clinical Trial Presenter: Demilade Adedinsewo November 13, 2023
Presentation AHA 2023 Two Randomized Controlled Trials of Nudges to Encourage Referrals to Centralized Pharmacy Services for Evidence-Based Statin Initiation in High-Risk Patients: The SUPER LIPID Program Presenter: Alexander C. Fanaroff November 13, 2023